The HER2 × CD63 BsAb showed strong internalization, lysosomal accumulation and cytotoxicity in HER2-positive tumor cells, and minimal internalization into HER2-negative cells (de Goeij et al. 2016). The gene discussed is ERBB2; the disease is neoplasm.